Ricky Hopson - Jul 26, 2022 Form 4 Insider Report for Catalent, Inc. (CTLT)

Role
Pres, Clinical Dev & Supply
Signature
/s/ Jose Ibietatorremendia, attorney-in-fact
Stock symbol
CTLT
Transactions as of
Jul 26, 2022
Transactions value $
-$96,986
Form type
4
Date filed
7/28/2022, 07:59 PM
Previous filing
Feb 1, 2022
Next filing
Aug 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Sale -$33.4K -312 -1.8% $106.90 17K Jul 26, 2022 Direct F1, F2, F3
transaction CTLT Common Stock Award $0 +651 +3.82% $0.00 17.7K Jul 26, 2022 Direct F2, F4
transaction CTLT Common Stock Sale -$63.6K -591 -3.34% $107.67 17.1K Jul 27, 2022 Direct F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTLT Options to purchase Common Stock Award $0 +2.83K $0.00 2.83K Jul 26, 2022 Common Stock 2.83K $107.63 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
F2 Includes restricted stock units.
F3 The number of securities reported reflects the acquisition since August 30, 2021 of 274 shares of the Issuer's common stock pursuant to the Issuer's Employee Stock Purchase Plan in transactions exempt from Section 16(b).
F4 Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.
F5 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
F6 Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
F7 The options vest and become exercisable in four equal annual installments beginning on July 26, 2023.